Key Takeaways
- A randomized trial involving 76 adults aged 60 or older found that six to eight days of supervised exercise, nutritional support and psychological preparation helped preserve walking capacity after stomach cancer surgery. Seventy patients were included in the final analysis.
- About one month after surgery, the prehabilitation group had a 32.2-meter advantage over standard care in the change in six-minute walking distance. Whether this translated into greater independence was not measured.
- Postoperative complications occurred in 11.8% of prehabilitation patients and 38.9% of controls. The trial was too small to establish a reliable reduction in complication risk.
- Patients receiving prehabilitation reached several recovery milestones sooner and spent fewer days in hospital after surgery. Total hospitalization was unchanged because their preoperative admissions were longer.
- Larger randomized trials and clinical guidelines support preparing patients before major surgery, but the ideal duration, delivery setting and combination of treatments remain uncertain.
What Can One Week of Preparation Achieve?
Supervised walking and physical preparation may help older adults preserve mobility following stomach cancer surgery, according to a small randomized trial.
People preparing for stomach cancer surgery may have little time to improve their physical condition before an operation. Conventional prehabilitation programs often last several weeks, combining exercise, nutritional support and psychological preparation.
A randomized trial from China tested a shorter approach: six to eight days of supervised preparation during a preoperative hospital admission.
The study by Zheng and colleagues, published in Supportive Care in Cancer on November 19, 2026, involved adults aged 60 or older scheduled for laparoscopic gastrectomy, an operation that removes part or all of the stomach.
Its main finding concerned walking capacity. Approximately one month after surgery, patients who received the program had maintained more of their baseline walking ability than those receiving standard care.
Several secondary outcomes also favored prehabilitation, including complications and early recovery milestones. Those findings require more caution because the trial was designed primarily to assess walking distance.
Another result changes the practical interpretation: patients spent fewer days in hospital after surgery, but their total hospital stay was not shorter.
How the Trial Worked
Researchers screened 90 patients at a tertiary hospital in China between June 2023 and October 2024. They randomly assigned 76 participants, with 38 in each group.
All participants were at least 60 years old, had confirmed gastric adenocarcinoma and could walk independently. They were classified as American Society of Anesthesiologists physical status I to III, indicating a range from relatively healthy patients to those with severe but not immediately life-threatening systemic disease.
People with metastatic cancer, severe cardiopulmonary disease or cognitive impairment preventing participation were excluded.
Six patients were excluded after randomization. Four were from the prehabilitation group: two began treatment before surgery, one declined surgery and one withdrew consent. Two were from the control group: one began treatment before surgery and one declined the operation.
The final analysis included 34 prehabilitation patients and 36 controls.
Participants generally had preserved mobility before surgery. Their baseline six-minute walking distance was approximately 448 meters. About 24% were at nutritional risk, and roughly 54% had other medical conditions.
The groups had broadly similar baseline characteristics, although distal gastrectomy was more common in the prehabilitation group: 55.9% versus 38.9%. This imbalance is relevant when interpreting postoperative complications.
Exercise, nutrition and psychological support
Patients assigned to prehabilitation received daily supervised exercise sessions lasting approximately 30 minutes.
Each session included a warm-up, 20 minutes of brisk walking or stationary cycling, and stretching. Participants also performed resistance exercises using elastic bands or body weight.
The aerobic exercises were performed at an effort described as fairly light to somewhat hard. The program was adjusted to each patient’s physical condition.
Nutritional care was individualized. Everyone received dietary counseling, while nine patients identified as being at nutritional risk were prescribed oral nutritional supplements.
The nutritional plan targeted approximately 1.2 to 1.5 grams of protein per kilogram of body weight daily for patients requiring supplementation.
Psychological support included relaxation techniques, coping strategies and calming music before bedtime.
Controls received routine preoperative education, nutritional screening and standard perioperative care. Patients at nutritional risk could receive dietary guidance, but oral supplements were not routinely provided.
Both groups followed the hospital’s usual postoperative recovery pathway.
Could patients complete the program?
Adherence was high.
Participants completed 243 of 248 planned exercise sessions, or 98.0%, and 244 of 248 psychological support sessions, or 98.4%.
They also consumed 172 of 180 prescribed nutritional supplement servings, an adherence rate of 95.6%.
Fatigue accounted for the five missed exercise sessions. The researchers identified no serious adverse events related to the intervention.
These findings suggest the program was feasible for the patients enrolled. They do not establish that people with severe frailty or substantial mobility limitations would tolerate the same schedule.
Walking Capacity Was Better Preserved
The trial’s primary outcome was the change in six-minute walking distance from baseline to 28–35 days after surgery.
The six-minute walk test is a simple measure of physical capacity. Patients walk as far as they comfortably can in six minutes, and researchers record the distance covered. It provides an indication of walking endurance, although it does not directly measure how independently someone manages everyday activities.
Before surgery, walking distance increased by an average of 31.53 meters in the prehabilitation group. It declined by 2.19 meters among controls.
At the postoperative assessment, the prehabilitation group remained an average of 6.00 meters above baseline. Controls were 26.20 meters below their starting point.
The difference between groups in the change from baseline was 32.2 meters, with a P value below 0.001.
This was a difference in how walking capacity changed, not simply a 32.2-meter difference between the distances patients walked at follow-up.
The result was statistically significant. Whether patients experienced a meaningful improvement in daily life is a separate question.
Is 32.2 meters clinically meaningful?
The researchers had assumed a 54-meter difference when calculating the trial’s sample size. The observed effect was smaller.
A useful benchmark comes from a 2014 study by Antonescu and colleagues published in Surgery, which examined recovery after abdominal surgery.
Using patients’ assessments of their health, the researchers estimated a minimal clinically important difference of 14 meters for the six-minute walk test, with a 95% confidence interval of 9 to 18 meters.
A minimal clinically important difference is an estimate of the smallest change patients are likely to notice or consider important.
Zheng’s observed 32.2-meter difference exceeds the 14-meter estimate. It also falls within or above several published estimates of clinically important improvements in walking distance.
This suggests the finding could matter to patients rather than being merely a statistical difference.
However, there is no universally accepted threshold for a meaningful change in six-minute walking distance after stomach cancer surgery.
Estimates from other surgical populations may not apply directly to older adults undergoing gastrectomy. The amount of improvement a patient notices may also differ from the amount of postoperative decline considered clinically important.
The trial did not measure whether patients could manage everyday activities more independently, return to their usual routines sooner or maintain their walking ability over several months.
For now, the evidence supports better preservation of walking capacity approximately one month after surgery. Whether that translates into a lasting improvement in daily life remains uncertain.
Hospital Days Shifted Rather Than Disappeared
Patients receiving prehabilitation spent an average of 10.06 days in hospital after surgery, compared with 13.31 days for controls.
The difference of approximately 3.25 postoperative days was statistically significant (P = 0.008).
Before surgery, however, the prehabilitation group had already spent considerably longer in hospital: 8.71 days versus 4.97 days.
That represented approximately 3.74 additional preoperative days.
Total hospitalization averaged 19.76 days with prehabilitation and 19.28 days with standard care. The difference was not statistically significant (P = 0.739).
The reported total hospital stays are approximately one day longer than the sums of the preoperative and postoperative periods. The researchers did not explain the difference in how these periods were counted.
This reporting detail does not change the main finding: total hospitalization was similar between groups despite fewer postoperative days in the prehabilitation group.
The program effectively shifted hospital time toward preparation without demonstrating a reduction in overall inpatient days.
Local scheduling may have contributed. At the participating hospital, patients were admitted for preoperative investigations and operating-room scheduling, and elective surgery was not performed on weekends.
A hospital with shorter routine preoperative admissions might face a different calculation. Delivering preparation at home or through outpatient visits could also change the resources required.
No formal economic evaluation was conducted. The trial therefore cannot show whether the additional preoperative supervision and nutritional support were cost-effective.
Fewer Complications, but Not Definitive Proof
Complications occurred in four of 34 prehabilitation patients (11.8%) and 14 of 36 controls (38.9%) within approximately one month of surgery.
The nominal P value was 0.009.
Pulmonary infections accounted for much of the difference, affecting three patients in the intervention group and 11 controls.
Mild complications, classified as Clavien–Dindo grade I or II, also occurred in three intervention patients and 11 controls.
The Clavien–Dindo system grades surgical complications according to the treatment they require. Lower grades generally involve less intensive treatment, while higher grades include complications requiring major interventions or intensive care.
Severe complications were uncommon. One patient receiving prehabilitation and three controls experienced a grade III or higher event. That difference was not statistically significant (P = 0.615).
Two control patients experienced anastomotic leakage, meaning leakage from a surgically joined section of the digestive tract. One intervention patient developed chylous leakage, involving lymphatic fluid, and one postoperative death occurred in the control group.
These findings are encouraging but uncertain.
The trial was designed around walking capacity, not complications. Only 18 participants experienced a complication, and the secondary analyses were not adjusted for multiple comparisons.
The higher proportion of distal gastrectomies in the prehabilitation group could also have influenced the results.
The researchers reported blinded outcome assessment, including evaluation of pulmonary infections by respiratory physicians who did not know patients’ treatment assignments. Other complications were recorded by a blinded research assistant, and data analysts were also blinded.
However, patients and treating clinicians knew which intervention had been assigned, leaving some potential for differences in care and reporting.
The study provides a reason to investigate complication prevention in larger trials. It does not establish the size of any protective effect.
Patients Reached Recovery Milestones Sooner
The prehabilitation group first stood or walked approximately 7.7 hours sooner than controls.
Patients also passed gas about 5.9 hours earlier and resumed oral intake roughly 0.6 days sooner.
All three comparisons had nominal P values below 0.001.
Patients receiving prehabilitation also reported better recovery quality on postoperative days three, five and seven, measured using the 15-item Quality of Recovery questionnaire.
Anxiety and depression scores did not differ significantly between groups.
These findings need careful interpretation because neither patients nor care providers were blinded to treatment assignment.
Additional encouragement or different expectations could have affected the timing of recovery activities. Patients’ knowledge that they had completed a preparation program could also have influenced their self-reported recovery scores.
The results are consistent with better early recovery, but the trial cannot determine how much came from the intervention itself rather than expectations or additional clinical attention.
What Larger Trials Tell Us
The Zheng trial is not the only evidence supporting prehabilitation before stomach cancer surgery. Its distinctive feature is the short intervention period.
A multicenter trial in frail older adults
A particularly relevant comparison is the GISSG+2201 randomized clinical trial by Sun and colleagues, published in JAMA Surgery in 2026.
The study involved 15 centers in China and randomized 368 older patients with frailty who were undergoing radical gastrectomy. Its modified intention-to-treat analysis included 347 patients.
Unlike Zheng’s study, GISSG+2201 enrolled patients specifically identified as frail. The intervention lasted at least two weeks and was added to an enhanced recovery after surgery pathway.
Postoperative complications occurred in 17.2% of prehabilitation patients and 28.7% of controls (P = 0.01).
The prehabilitation group also improved its six-minute walking distance by an average of 24 meters before surgery.
The larger, multicenter design and complication-focused primary outcome provide stronger evidence that multimodal prehabilitation can improve outcomes in selected older patients with gastric cancer.
The findings do not establish that Zheng’s shorter inpatient program produces the same effects. The trials differed in duration, participant frailty and comparison care.
Longer programs have also shown functional benefits
In a 2018 randomized trial published in JAMA Surgery, Minnella and colleagues studied exercise and nutritional prehabilitation before surgery for esophageal or stomach cancer.
Among 51 patients included in the primary analysis, walking distance increased by 15.4 meters in the prehabilitation group and declined by 81.8 meters in controls four to eight weeks after surgery.
The between-group difference was approximately 97 meters.
That effect was larger than Zheng’s, but differences in patients, intervention duration and follow-up prevent a reliable conclusion that longer programs necessarily work better.
Bausys and colleagues, writing in the British Journal of Surgery in 2023, examined a personalized, largely home-based program for patients undergoing surgery for gastric cancer.
Among 122 analyzed participants, complications occurred in 23.7% of prehabilitation patients and 59.3% of controls within 90 days. The reported risk ratio was 0.40.
The program lasted considerably longer than Zheng’s, averaging approximately 92 days across different treatment pathways.
Severe complication rates were similar between groups, and hospital stay did not differ significantly.
Because much of the preparation occurred at home, the program did not require the same additional preoperative inpatient period.
Evidence from another one-week program
Mu and colleagues reported a single-center randomized trial in Frontiers in Nutrition in 2026.
Of 150 randomized patients, 131 completed the study. The intervention lasted one week before radical gastrectomy.
Complications occurred in 9.1% of prehabilitation patients and 26.2% of controls.
The study also reported fewer pulmonary infections, earlier recovery milestones and improved preoperative walking capacity.
Unlike Zheng’s trial, Mu’s study designated postoperative complications as its primary outcome.
The two studies support further investigation of short programs, although neither can establish how well the approach works across different hospitals.
What the pooled evidence shows
A 2026 systematic review and meta-analysis by Wu and colleagues in World Journal of Surgical Oncology examined six randomized trials involving 972 participants undergoing gastrectomy.
Prehabilitation was associated with fewer overall complications, with a pooled risk ratio of 0.56, and fewer pulmonary complications, with a pooled risk ratio of 0.41.
A risk ratio below 1 indicates that the outcome occurred less frequently in the intervention groups across the studies.
Postoperative hospital stays were approximately 1.48 days shorter on average.
The authors rated the certainty of evidence for these outcomes as moderate. Findings for severe complications and readmissions were inconclusive, and walking-distance results varied substantially.
The review’s search ended in June 2026, before Zheng’s study was published.
Taken together, the trials suggest that prehabilitation can benefit selected patients undergoing gastrectomy. They do not yet establish the best duration, setting or combination of components.
Nutritional Care Is an Important Part of the Comparison
Zheng’s program combined exercise, nutrition and psychological support. Because the components were delivered together, the study cannot identify which produced the walking benefit.
The nutritional difference between groups deserves particular attention.
Patients at nutritional risk in the prehabilitation group received oral nutritional supplements. Comparable control patients received dietary guidance but were not routinely given supplements.
That distinction matters because nutritional support is already an established part of surgical care.
The European Society for Clinical Nutrition and Metabolism (ESPEN) recommends assessing nutritional status before major surgery and providing appropriate nutritional treatment when malnutrition or nutritional risk is identified.
Its 2021 practical guideline on clinical nutrition in surgery supported preoperative oral nutritional supplements for selected malnourished and high-risk surgical patients, preferably before hospital admission when feasible.
The updated 2025 ESPEN guideline continues to emphasize early identification of nutritional problems and individualized treatment, particularly for patients undergoing major gastrointestinal surgery.
A positive nutritional screening result does not necessarily mean every patient needs the same supplement regimen. Treatment decisions depend on nutritional assessment, usual dietary intake, the planned operation and individual clinical needs.
In Zheng’s trial, patients at nutritional risk in the prehabilitation group received oral nutritional supplements, while comparable control patients received dietary assessment and guidance without routine supplementation.
This difference complicates interpretation because the trial did not separate the effects of exercise, nutrition and psychological support.
Consequently, the observed benefit may reflect the combined intervention, the additional nutritional treatment or both. The study cannot establish how much each component contributed.
Nor does the comparison, by itself, establish that the control group received inappropriate care.
What the Study Cannot Establish
The trial was conducted at one hospital and included only 70 patients in the final analysis.
Participants could walk independently and generally had preserved physical functioning before surgery. The findings may not apply to people with severe frailty, marked malnutrition or major mobility limitations.
Six patients were excluded after randomization, creating a possible source of selection bias.
Patients and care providers knew which treatment had been assigned. This could have affected subjective recovery ratings and some early recovery measures, despite the use of blinded outcome assessment.
Follow-up ended approximately one month after surgery. Researchers did not establish whether the walking advantage persisted or improved long-term independence, quality of life or survival.
The program was also delivered during a hospital admission. Its results cannot be assumed to apply to a home-based or outpatient version lasting the same number of days.
Finally, the trial did not assess costs. Improved functional outcomes and unchanged total hospital stay need to be considered together when evaluating the program’s practical value.
What Patients Can Take From the Findings
For older adults preparing for stomach cancer surgery, this study suggests that even a short period of supervised physical preparation may help preserve walking ability during early recovery.
The strongest evidence from this small trial concerns walking capacity approximately one month after surgery. Fewer complications were also observed, but the study was too small to establish a reliable reduction in complication risk. Total hospital stay was not shorter.
Patients preparing for surgery may wish to discuss three questions with their surgical team:
- Could supervised exercise help before surgery? A clinician or rehabilitation specialist can assess whether walking, stationary cycling or light resistance exercises are appropriate.
- Should nutritional status be assessed? Patients experiencing weight loss, poor appetite or difficulty eating may benefit from individualized nutritional evaluation and treatment.
- Can preparation take place outside the hospital? Depending on the healthcare system and the patient’s condition, supervised home-based or outpatient programs may be available.
Patients should not begin strenuous exercise or take nutritional supplements solely because of these findings. The safest approach depends on their physical condition, nutritional needs, other illnesses and planned treatment.
For hospitals and researchers, an important next step is determining whether a short program can preserve walking capacity without requiring additional inpatient preparation days.
Larger studies will also need to establish whether the benefits persist beyond the first postoperative month and translate into greater independence and better quality of life.
Funding and Disclosures
The Zheng study was funded by the Startup Fund for Scientific Research at Fujian Medical University (grant 2022QH1270).
The authors declared no competing interests. No commercial funding was listed.
References
Antonescu, I., Scott, S., Tran, T. T., Mayo, N. E., & Feldman, L. S. (2014). Measuring postoperative recovery: What are clinically meaningful differences? Surgery, 156(2), 319–327. https://doi.org/10.1016/j.surg.2014.03.005
Bausys, A., Luksta, M., Anglickiene, G., et al. (2023). Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: Randomized clinical trial. British Journal of Surgery, 110(12), 1800–1807. https://doi.org/10.1093/bjs/znad312
Minnella, E. M., Awasthi, R., Loiselle, S.-E., et al. (2018). Effect of exercise and nutrition prehabilitation on functional capacity in esophagogastric cancer surgery: A randomized clinical trial. JAMA Surgery, 153(12), 1081–1089. https://doi.org/10.1001/jamasurg.2018.1645
Mu, G.-C., Tu, Y.-H., Xie, H.-L., Liu, S.-Y., Jia, K., He, M.-Y., Chen, Y.-Y., & Chen, J.-Q. (2026). Multimodal prehabilitation enhances perioperative outcomes in gastric cancer patients: A single-center randomized controlled trial. Frontiers in Nutrition, 12, Article 1676180. https://doi.org/10.3389/fnut.2025.1676180
Sun, Y., Tian, Y., Cao, S., et al. (2026). Supervised multimodal prehabilitation and clinical outcomes in older patients with frailty and gastric cancer: The GISSG+2201 randomized clinical trial. JAMA Surgery, 161(3), 223–233. https://doi.org/10.1001/jamasurg.2025.6256
Weimann, A., Braga, M., Carli, F., et al. (2021). ESPEN practical guideline: Clinical nutrition in surgery. Clinical Nutrition, 40(7), 4745–4761. https://doi.org/10.1016/j.clnu.2021.03.031
Weimann, A., Bezmarevic, M., Braga, M., et al. (2025). ESPEN guideline on clinical nutrition in surgery: Update 2025. Clinical Nutrition, 53, 222–261. https://doi.org/10.1016/j.clnu.2025.08.029
Wu, C., et al. (2026). Structured prehabilitation before gastrectomy for gastric cancer: A systematic review and meta-analysis of randomized trials. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-026-04650-7
Zheng, Z., Guo, M., Shi, L., Cai, F., Liu, J., Lin, H., Wu, W., Ye, C., Huang, X., & Su, Y. (2026). Ultra-short-term in-hospital multimodal prehabilitation in older patients undergoing laparoscopic gastrectomy for gastric cancer: A randomized controlled trial. Supportive Care in Cancer, 34, Article 1250. https://doi.org/10.1007/s00520-026-11516-x




